Takeda got an approval from the U.S. Food and Drug Administration (FDA) for the additional Biologics License Application (BLA) for VONVENDI
The recent GST Reform by the Government of India to exempt individual health and life insurance premiums, along with the rationalization of healthcare goods and services, marks a landmark step in its mission of achieving Affordable Healthcare and...
.jpeg){kind=spacer}
The National Pharmaceutical Pricing Authority (NPPA) has handed a special ceiling price for the product of Meropenem Powder for Injection in dual chamber bags by Gufic Biosciences Limited
The GST Council has removed the 12% Goods and Services Tax (GST) on 33 high-cost life-saving drugs and diagnostic kits, resulting in these items being tax-free and thus relieving the burden on patients.
.jpeg){kind=spacer}
Novo Nordisk India’s proposal to discontinue several recombinant DNA (rDNA) origin insulin products from the Indian market has been approved by the Subject Expert Committee
India is planning to increase pharmaceutical exports to Russia, the Netherlands and Brazil, diversifying its markets beyond the United States, which remains its largest buyer. Two industry sources confirmed the move, highlighting tariff-related uncer
The health and wellness industry, Zydus Wellness Limited, announced that its wholly owned subsidiary, Alidac UK Limited
India is scheduled to overhaul the regulations under the Biological Diversity Act, 2002 with the intention of boosting the ayurvedic medicine
Bayer has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for gadoquatrane, an investigational macrocyclic gadolinium-based contrast agent
Shilpa Medicare Limited has finalized a definitive agreement with Pharmaceutical Industries & Biological Products (PPI), a leading enterprise in Saudi Arabia, through its subsidiary Koanna International FZ LLC
, CDSCO.jpg)